Kronos Bio Stock Forward View

Kronos Bio Additional Predictive Modules

Most predictive techniques to examine Kronos price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Kronos using various technical indicators. When you analyze Kronos charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur. A naive forecasting model for Kronos Bio is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Kronos Bio value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Kronos Bio Naive Prediction Price Forecast For the 8th of February

Given 90 days horizon, the Naive Prediction forecasted value of Kronos Bio on the next trading day is expected to be 0.82 with a mean absolute deviation of 0.03, mean absolute percentage error of 0, and the sum of the absolute errors of 1.95.

Kronos Bio Stock Forecast Pattern

Backtest Kronos Bio

Kronos Bio Price Prediction

Research Analysis

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Kronos Bio stock data series using in forecasting. Note that when a statistical model is used to represent Kronos Bio stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality. This model is not at all useful as a medium-long range forecasting tool of Kronos Bio. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Kronos Bio. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Kronos Bio

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kronos Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.88 0.88 0.88 Details

Intrinsic Valuation Low Real High 0.71 0.71 0.97 Details

Bollinger Band Projection (param) Low Middle High 0.61 0.79 0.97 Details

Kronos Bio After-Hype Price Density Analysis

Kronos Bio Estimiated After-Hype Price Volatility

Kronos Bio Stock Price Outlook Analysis

Notes

Kronos Bio Hype Timeline

Kronos Bio is now traded for 0.88. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Kronos is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on Kronos Bio is about 0.0%, with the expected price after the next announcement by competition of 0.88. About 24.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.67. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Kronos Bio recorded a loss per share of 1.07. The entity had not issued any dividends in recent years. The firm had 3:2 split on the 3rd of November 2003. Given the investment horizon of 90 days the next estimated press release will be in about 6 days. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Kronos Bio Related Hype Analysis

Kronos Bio Related Equities

Risk & Return

Correlation

Kronos Bio Market Strength Events

Kronos Bio Risk Indicators

Story Coverage note for Kronos Bio

Kronos Bio Short Properties

Other Consideration for investing in Kronos Stock